 Exhibit 99.1 |
 Disclosure Forward-Looking Statements: This presentation includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. The use of words such as “may”, “might”, “should”, “will”, “expect”, “plan”, “anticipate”, “believe”, “estimate”, “project”, “forecast”, “outlook”, “intend”, “future”, “potential” or “continue”, and other similar expressions are intended to identify forward-looking statements. All of these forward-looking statements are based on estimates and assumptions by our management as of the date of this presentation that, although we believe to be reasonable, are inherently uncertain. Forward-looking statements involve risks and uncertainties that could cause the Company’s actual results or circumstances to differ materially from those expressed or implied by forward-looking statements. These risks and uncertainties include, among others, the following: the cyclicality of the markets that the Company serves; a delay, significant reduction in or loss of purchases by large customers; fluctuations in energy prices; changes in government energy policy or failure of expected changes in policy to materialize; the potential for negative developments in the natural gas industry related to hydraulic fracturing; competition; economic downturns and deteriorating financial conditions; our ability to manage our fixed-price contract exposure; our reliance on key suppliers and potential supplier failures or defects; the modification or cancellation of orders in our backlog; the Company’s ability to successfully manage its costs and growth, including its ability to successfully manage operational expansions and the challenges associated with efforts to acquire and integrate new product lines or businesses; changes in government healthcare regulations and reimbursement policies; general economic, political, business and market risks associated with the Company’s global operations and transactions; fluctuations in foreign currency exchange and interest rates; the financial distress of third parties; the loss of key employees and deterioration of employee or labor relations; the pricing and availability of raw materials; the regulation of our products by the U.S. Food & Drug Administration and other governmental authorities; potential future impairment of the Company’s significant goodwill and other intangibles; the cost of compliance with environmental, health and safety laws; additional liabilities related to taxes; the impact of severe weather; litigation and disputes involving the Company, including product liability, contract, warranty, employment and environmental claims; technological security threats; risks associated with our indebtedness, leverage, debt service and liquidity; and volatility and fluctuations in the price of the Company’s stock. For a discussion of these and additional risks that could cause actual results to differ from those described in the forward-looking statements, see disclosure under Item 1A. “Risk Factors” in the Company’s most recent Annual Report on Form 10-K and other recent filings with the Securities and Exchange Commission, which should be reviewed carefully. Please consider the Company’s forward-looking statements in light of these risks. Any forward-looking statement speaks only as of its date. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. 1 |
 GTLS: GAS TO LIQUID SYSTEMS Technology leader that provides high-end equipment to the energy industry, which is the largest end-user of Chart’s products One of the leading suppliers in all primary markets served Global footprint for our operations on four continents with approximately 3,800 employees Worldwide earnings with approximately 60% of sales derived from outside the U.S. Company Overview Chart Industries is a leading provider of highly engineered cryogenic equipment for the hydrocarbon, industrial gas, and biomedical markets Asia 19% U.S. 42% Americas (Non-US) 9% RoW 6% Europe 24% 2011 Sales by Segment Energy 48% BioMedical 25% General Industrial 27% 2011 Sales by Region 2011 Sales by End-User Energy & Chemicals 26% Distribution & Storage 49% BioMedical 25% 2 |
 GTLS: GAS TO LIQUID SYSTEMS Energy & Chemicals (E&C) Segment Overview Heat Exchanger Cold Box Production Brazed Aluminium Heat Exchangers 44% Cold Boxes and LNG VIP 23% 2011 Sales by Product / Region Highlights Technology leader – providing heat exchangers and cold boxes critical to LNG, Olefin petrochemicals, natural gas processing and industrial gas markets – Separation, liquefaction and purification of hydrocarbon and industrial gases Market leader – leading industry positions worldwide Manufacturing leader – one of three global suppliers of mission-critical LNG and LNG liquefaction equipment Selected Products Americas (Non-US) 11% Middle East & RoW 18% Asia 23% U.S. 47% Europe 1% 3 Air Cooled Heat Exchangers 33% |
 GTLS: GAS TO LIQUID SYSTEMS Distribution & Storage (D&S) Segment Overview 2011 Sales by Product / Region Highlights Balanced customer base – 46% of segment sales derived from products used in energy applications Strategic footprint – manufacturing located near growing end markets and lower-cost countries – Positioned to capitalize on strong expected growth in Asia and North America – Continued investment in key global manufacturing facilities Bulk MicroBulk Distribution Storage Selected Products Satellite LNG Storage Bulk Storage Systems 36% Packaged Gas Systems 28% VIP, Systems and Components 9% Parts, Repair and On- Site Service 9% Beverage Liquid CO 2 Systems 6% LNG Terminals and Vehicle Fuel Systems 12% Americas (Non-US) 10% RoW 3% Asia 21% U.S. 42% Europe 24% 4 |
 GTLS: GAS TO LIQUID SYSTEMS BioMedical Segment Overview 2011 Sales by Product / Region Highlights Strong growth – increase in oxygen respiratory therapy and biomedical research, led by international markets, expected Robust end markets include: – Home healthcare and nursing homes – Hospitals and long-term care – Biomedical and pharmaceutical research – Animal breeding Portable Oxygen Lab Storage Stainless Steel Freezer End-Use Consumption Liquid Oxygen (LOX) Therapy Systems 52% Biological Storage Systems 30% Selected Products Americas (Non-US) 5% U.S. 38% Europe 46% Asia 10% RoW 1% 5 Non-LOX Respiratory Therapy Systems 18% |
 GTLS: GAS TO LIQUID SYSTEMS Global Manufacturing and Distribution Platform Operating leverage provides the flexibility to expand and reduce capacity as needed Major manufacturing locations include: China, Changzhou (D&S and E&C) and Chengdu (BioMedical) Czech Republic, Decin (D&S) Georgia, Canton and Minnesota, New Prague/Owatonna (D&S and BioMedical) Wisconsin, La Crosse, Louisiana, New Iberia and Oklahoma, Tulsa (E&C) Expansion of facilities in China, Louisiana and Minnesota are currently in process Manufacturing facilities are strategically located in lower-cost countries and near centers of demand Asia-Pacific North America 6 Corporate Energy & Chemicals Distribution & Storage BioMedical Europe |
 Growth Opportunities 7 •Global base load LNG projects • Growth in natural gas processing • Emerging market opportunities •Global LNG opportunity • Strong relationships with Industrial Gas customers • Demand for Industrial Gas projected to increase 8% per year •Aging demographics • Product expansion • Increasing biological research BioMedical GTLS: GAS TO LIQUID SYSTEMS D&S E&C |
 GTLS: GAS TO LIQUID SYSTEMS Natural gas expansion – Natural gas demand is expected to continue to grow at a pace faster than coal and oil, and will be heavily weighted towards emerging economies, which is expected to drive demand for Chart’s products LNG growth leader – The natural gas industry is expected to invest approximately $720 billion in LNG facilities from 2009 to 2035, with LNG reaching 25% of world demand in 2035 (Source: International Energy Agency – World Energy Outlook 2011, Golden Age of Gas Scenario) Natural Gas Expected To Grow Globally 8 Source: ExxonMobil – The Outlook for Energy, A View to 2040 |
 GTLS: GAS TO LIQUID SYSTEMS Increasing natural gas penetration as a viable energy source and transportation fuel due to its high energy density, lower costs, cleaner emissions profile, and plentiful supply due to improved drilling technologies (e.g. shale gas). U.S. trucking is converting a portion of its fleets to natural gas. Recent announcements in domestic LNG infrastructure by major natural gas producers and equipment providers, as well as recent order intake have validated expectations China’s twelfth 5-year plan (2011 - 2015) mandates an increase in gas use as a percentage of energy consumption from less than 4% to over 8% Dramatic increase in imported LNG in China is in process and is expected to continue, with significant investment in infrastructure, including LNG transportation and storage equipment. According to the China Industrial Gas Association, China will complete the construction of 17 LNG terminals during the twelfth 5-year period with capacity of 65 million tons per year Lack of pipeline infrastructure in China requires “virtual pipeline” with LNG Chart provides a broad offering of products and solutions for the full LNG value chain: LNG liquefiers, transportation equipment, terminal storage equipment and vehicle tanks for both on-road and off-road heavy duty vehicles and marine applications LNG Value Chain Opportunities 9 |
 GTLS: GAS TO LIQUID SYSTEMS Strong Track Record of Successful Execution ¹Included in 2005 are non-recurring costs of $26.5 million for the acquisition of Chart Industries by First Reserve During last growth cycle Company leveraged its flexible manufacturing platform resulting in operating income growth that outpaced sales Flexible cost structure and good execution allowed for aggressive response to economic downturn resulting in higher operating income level than last cycle low point 10 Similar or higher growth, leveraged by acquisitions, expected to occur again during the current growth cycle The return of large contract orders and the improvement in base order levels have confirmed a new growth cycle 1 0 20 40 60 80 100 120 140 160 0 100 200 300 400 500 600 700 800 900 2004 2005 2006 2007 2008 2009 2010 2011 LTM 2012 Sales Operating Income Last Growth Cycle CAGR (2004-2008) Sales 25% Oper. Inc. 38% Large Contract Orders Base Orders 0 50 100 150 200 250 300 350 400 450 Q1 2010 Q2 2010 Q3 2010 Q4 2010 Q1 2011 Q2 2011 Q3 2011 Q4 2011 Q1 2012 |
 GTLS: GAS TO LIQUID SYSTEMS Historical Orders and Backlog Quarter-end Backlog ($MM) 11 Quarterly Orders ($MM) 0 100 200 300 400 500 600 700 Q3 2009 Q1 2009 Q2 2009 Q3 2010 Q4 2010 Q1 2011 Q2 2011 Q3 2011 Q4 2011 Q1 2012 Q4 2009 Q1 2010 Q2 2010 E&C D&S BioMed 0 100 200 300 400 500 600 700 Q1 2012 Q4 2011 Q3 2011 Q2 2011 Q1 2011 Q4 2010 Q3 2010 Q2 2010 Q1 2010 Q4 2009 Q3 2009 Q2 2009 Q1 2009 D&S E&C BioMed |
 GTLS: GAS TO LIQUID SYSTEMS Outlook for 2012 12 Based on a substantial order backlog, solid financial resources, and an attractive portfolio of product solutions, we expect another solid year in 2012. We believe energy investments, especially in natural gas applications, are at an early-stage of a multi-year growth cycle. We anticipate continued growth in demand for our products as evidenced by record orders of $385 million in first quarter 2012. Quarterly order records were set at both E&C and D&S led by LNG opportunities. We have stepped up our investment in capacity to capture and execute on these opportunities, and our expansion plans are progressing as expected. Based on first quarter performance, record backlog and strong order trends, we reaffirmed our 2012 sales and earnings expectations. Sales for 2012 are expected to be in a range of $950 million to $1 billion. Full year earnings per diluted share are expected to be in a range of $2.60 to $2.90 per share. |
 GTLS: GAS TO LIQUID SYSTEMS Very Stable Business Model • Attractive industry with long-term customer relationships • Solid platform with worldwide presence and leading industry positions in all segments Summary of Investment Highlights 13 Strong Balance Sheet • Strong organic earnings should provide substantial free cash flow and liquidity • Permit continued accretive organic and inorganic growth Positioned for Significant Growth • Exploit LNG and NG growth • Opportunities with global infrastructure build-out • New product development and innovation • Expanded new business and inorganic pipeline Chart continues to represent a unique investment opportunity to capitalize on global energy demand, growth in natural gas use, and biomedical opportunities Flexible / Low Cost Capital Structure • 7 yr. $250 million convertible notes - 2% cash interest cost • Recently increased senior credit facility to $375 million, from $200 million, which adds liquidity and significantly improves ability to grow |